- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06194721
The Effect of Intra-pulpal Anesthesia With Cryotherapy on Intra-operative Pain
The Effect of Intra-pulpal Anesthesia With Cryotherapy on Intra-operative Pain During Root Canal Treatment on Mandibular Molars With Symptomatic Irreversible Pulpitis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study will be conducted on 40 mandibular molars in each group n = 20. The patient will be asked to pick an opaque sealed envelope that will contain a number 1 or 2. The resultant number will determine in which group the participants will be placed. Double blinding will be maintained in this study as the assessor and the patients will not be aware of their group.
Group 1: Will receive intrapulpal local anesthesia at 4-5 C after pulp exposure.
Group 2: Will receive intrapulpal local anesthesia at room temperature after pulp exposure.
Procedural steps:
- A history of present illness will be recorded from the patient and the suspected tooth will be tested for vitality using a cold test and an electric pulp tester, to ensure the correct diagnosis is reached.
- Once the diagnosis is confirmed to be symptomatic irreversible pulpitis, the patient will receive an inferior alveolar nerve block (2% lidocaine 1:100,000).
- A rubber dam will be used to achieve isolation, and an access cavity will be prepared using a high-speed handpiece, a round bur (no.4), and an Endo-Z bur.
- If the patient reports feeling any pain, the procedure will stop, and the patient will be presented with a Visual Analogue Scale and asked to rate the pain on a scale of 1-10. Pain levels of more than 5 will be included in the study.
- Intra-pulpal anesthesia (2% lidocaine 1:100,000) will be administered, and the needle will be surrounded by a piece of sterile gauze to ensure it is under back pressure.
- After administering the intra-pulpal injection, the patient will again be presented with the same VAS and asked to rate their current pain.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ajman Emirate
-
Ajman, Ajman Emirate, United Arab Emirates, 4184
- Gulf Medical University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients with mandibular molars diagnosed with symptomatic irreversible pulpitis.
- Mandibular molars with closed apices.
- Patients who are experiencing pain during access cavity drilling above 5 visual analog scale.
Exclusion Criteria:
• Patients with a known allergy to lidocaine.
- Root canal-treated mandibular molars.
- Patients with systemic diseases.
- Mandibular molars with open apices.
- Mandibular molars with external/internal resorption.
- Non-restorable mandibular molars.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cryotherapy
|
Intrapulpal cold local anesthesia at 4-5 c temperature
|
|
Active Comparator: Room temperature
|
Intrapulpal cold local anesthesia at room temperature
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of intraoperative pain
Time Frame: Intraoperative
|
Evaluation of intraoperative pain intensity using a visual analog scale.
The visual analog scale measures pain intensity.
The visual analog scale consists of a 10 cm line, with 2 endpoints representing 0 ( no pain) and 10 (pain as bad it could be)
|
Intraoperative
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-COD-STD-109-JUNE-2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.